Zhejiang Hengtong Stock Soars 10.05%, Hits Intraday High of CNY 6.02

Zhejiang Hengtong Holding Co., Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 10.05% on March 13, 2026. The stock reached an intraday high of CNY 6.02, marking a notable performance against the backdrop of a -0.82% decline in the China Shanghai Composite index for the same day. Over the past week, Zhejiang Hengtong has shown resilience with a 4.7% increase, while its year-to-date performance stands at 12.95%. Impressively, the stock has delivered a remarkable 113.48% return over the past year, significantly outperforming the broader market, which has seen a 21.93% increase. Despite these positive short-term trends, the company faces challenges in long-term growth, with net sales growing at an annual rate of 22.59% and operating profit at 11.94% over the last five years. The stock's valuation metrics, including a price-to-book ratio of 5.22 and a return on equity of 5.60%, reflect its current market position. As it continues to navigate the complexities of the industry, Zhejiang Hengtong remains a noteworthy entity in the financial landscape.